Write a research paper Based on what describe below:
1- introduction about the disease
2-Coronary Artery circulation
3- Coronary Artery Pathophysiology
4-Treatment
Coronary Artery disease
1. Introduction
a. Statistics and fact of coronary artery disease
b. Coronary circulation ( Rehman S, Khan A, 2020)
2. Coronary Artery disease: Pathophysiology
a. Atherosclerosis (Libby P, and Theroux. 2005.)
b. Risk factors
i. High and low LDL cholesterol
ii. High blood pressure
iii. Diabetes
iv. Smoking
v. Age
vi. Obesity
3. Treatment (Mayo Clinic: Coronary artery disease)
a. Lifestyle Changes
i. Eat healthy foods, exercise regularly and Quit smoking
ii. Control weight, blood pressure and cholesterol
iii. Keep diabetes under control and reduce stress
b. Drugs Treatment
i. Beta blockers
ii. Calcium channel blockers
iii. Ranolazine
iv. Nitrates
v. Nitroglycerin
vi. Angiotensin-converting enzyme (ACE) inhibitors
Bibliography
1. Boudonas G. E. (2010). β-Blockers in coronary artery disease management. Hippokratia, 14(4),
231–235. Collet, C., Capodanno, D., Onuma, Y. et al. Left main coronary artery disease:
pathophysiology, diagnosis, and treatment. Nat Rev Cardiol 15, 321–331 (2018).
https://doi.org/10.1038/s41569-018-0001-4
2. Price JF, MowbrayPI, Lee AJ, Rumley A, Lowe G, and Fowkes FG. Relationship Between Smoking
and Cardiovascular Risk Factors in the Development of Peripheral Arterial Disease and Coronary
Artery Disease; Edinburgh Artery Study. European Heart Journal, 1999/20,5/P 344–353,
https://doi.org/10.1053/euhj.1998.1194
3. Libby P, and Theroux. Pathophysiology of Coronary Artery Disease. Circulation. 2005;111:3481–
3488, https://doi.org/10.1161/CIRCULATIONAHA.105.537878
4. Judy WM. and Cheng. Ranolazine for the management of coronary artery disease, Clinical
Therapeutics, 2006, 0149-2918, P: 1996-2007. Doi.org/10.1016/j.clinthera.2006.12.009.
5. Jespersen L, Hvelplund A, Steen A, Frants P, Galatius S, Jan K. Madsen, Jørgensen E, Kelbæk H,
and Eva P. Stable Angina Pectoris with no Obstructive Coronary Artery Disease is associated with
increased risks of major adverse cardiovascular events. European Heart Journal, 2012, 33, P734–
744, doi.org/10.1093/eurheartj/ehr331
6. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE. Coronary Heart Disease:
https://www.nhlbi.nih.gov/health-topics/coronary-heartdisease#:~:text=Causes,the%20surface%20of%20the%20heart
7. Weightman, M. MBChB, Gibbs, M. MBBS, FANZCA, MD; Sheminant, RN, Eric G, Mahon, Barry D,
and et al. Drug Therapy Before Coronary Artery Surgery: Nitrates Are Independent Predictors of
Mortality and beta-Adrenergic Blockers Predict Survival. Anesthesia & Analgesia. 1999,88, 2. P:
286-291 doi: 10.1213/00000539-199902000-00011
8. Rehman S, Khan A, Rehman A. Physiology, Coronary Circulation.. In: StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from:
https://www.ncbi.nlm.nih.gov/books/NBK482413/
9. Centers for Disease Control and Prevention 2020. Heart Disease Facts.
https://www.cdc.gov/heartdisease/facts.htm.
Delivering a high-quality product at a reasonable price is not enough anymore.
That’s why we have developed 5 beneficial guarantees that will make your experience with our service enjoyable, easy, and safe.
You have to be 100% sure of the quality of your product to give a money-back guarantee. This describes us perfectly. Make sure that this guarantee is totally transparent.
Read moreEach paper is composed from scratch, according to your instructions. It is then checked by our plagiarism-detection software. There is no gap where plagiarism could squeeze in.
Read moreThanks to our free revisions, there is no way for you to be unsatisfied. We will work on your paper until you are completely happy with the result.
Read moreYour email is safe, as we store it according to international data protection rules. Your bank details are secure, as we use only reliable payment systems.
Read moreBy sending us your money, you buy the service we provide. Check out our terms and conditions if you prefer business talks to be laid out in official language.
Read more